Blog

Media

Potentially promising Alzheimer’s drug going forward

A drug created by the company Biogen might be able to slow the progression of Alzheimer’s Disease.

The company initially discontinued work on aducanumab when it started with disappointing results. They now say that a further analysis of that same data has actually suggested it may decrease cognitive loss in its treatment of Alzheimer’s Disease.

Dr. Andrew Frank speaks with Rob Snow on 580 CFRA

Dr. Andrew Frank of Bruyère spoke about it yesterday on CFRA. Dr. Frank suggests further trials will be necessary, but that this remains a positive development in the world of dementia.

Related Posts

Article
$47,900 OTF Grant Opens Window to Dementia Help Ottawa, ON – In 2021, the Dementia Society of Ottawa and Renfrew County received a $47,900 Resilient[...]
Le message français suit                   Public Health Agency of Canada investment enables The Dementia Society of Ottawa[...]
Article
Le message français suit Women in dementia are a marginalized majority. Curious to know more about how dementia affects women in Canada and around the[...]
Media
FOR IMMEDIATE RELEASE                                            [...]
Article
A dementia diagnosis can be life-changing for the person diagnosed, their caregiver and loved ones. To help you navigate this confusing and challenging journey, we[...]
Article
The Dementia Society loves seeing you at our free events! After successfully moving many programs online at the beginning of the pandemic, we are now reopening some in-person activities[...]